Insight Molecular Diagnostics Inc. — Director's Dealing 2025

Feb 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oncocyte Corp (OCX)
CIK: 0001642380
Period of Report: 2025-02-07

Reporting Person: SMITH PATRICK W (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-07	Common Stock, no par value	P	1077600	$2.05	Acquired	2872671	Indirect
2025-02-07	Common Stock, no par value	J	385814	$2.05	Acquired	3258485	Indirect

Footnotes

F1: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.

F2: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.

F3: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.